Vigil Neuroscience, Inc.
General ticker "VIGL" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $119.6M (TTM average)
Vigil Neuroscience, Inc. follows the US Stock Market performance with the rate: 12.4%.
Estimated limits based on current volatility of 0.5%: low 7.94$, high 7.96$
Factors to consider:
- Current price 130.3% above estimated high
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.93$, 3.45$]
- 2025-12-31 to 2026-12-31 estimated range: [1.40$, 4.37$]
Financial Metrics affecting the VIGL estimates:
- Negative: Non-GAAP EPS, $ of -2.06 <= 0.05
- Negative: Operating cash flow per share per price, % of -38.21 <= 1.99
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -20.97 <= 2.94
- Negative: Industry operating profit margin (median), % of -98.39 <= 0.07
- Negative: Operating profit margin, % of -100 <= 0.04
Short-term VIGL quotes
Long-term VIGL plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $68.88MM | $88.87MM | $89.68MM |
| Operating Income | $-68.88MM | $-88.87MM | $-89.68MM |
| Non-Operating Income | $0.58MM | $6.23MM | $5.43MM |
| R&D Expense | $47.44MM | $60.93MM | $62.31MM |
| Income(Loss) | $-68.31MM | $-82.64MM | $-84.26MM |
| Profit(Loss)* | $-67.73MM | $-82.64MM | $-84.26MM |
| Stockholders Equity | $189.08MM | $116.25MM | $71.64MM |
| Inventory | $10.56MM | $0.00MM | $0.00MM |
| Assets | $200.39MM | $140.86MM | $117.69MM |
| Operating Cash Flow | $-65.15MM | $-70.36MM | $-51.22MM |
| Capital expenditure | $0.92MM | $0.67MM | $0.01MM |
| Investing Cash Flow | $-0.92MM | $-65.14MM | $8.76MM |
| Financing Cash Flow | $161.25MM | $0.89MM | $29.49MM |
| Earnings Per Share** | $-2.14 | $-2.13 | $-2.07 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.